EuroEyes International Eye Clinic Limited (EUROEYES) has submitted its monthly return to the Hong Kong Exchanges and Clearing Limited for the period ended 31 July 2026, confirming no changes to its share structure and ongoing compliance with public float requirements.

The company’s authorised share capital remained unchanged at 1.00 billion ordinary shares with a par value of USD 0.01 each, equivalent to USD 10.00 million.

Issued share capital also saw no movement: EUROEYES closed July with 320.71 million ordinary shares in issue and held no treasury shares. Consequently, total issued share capital stood at 320.71 million shares, identical to the preceding month’s level.

Management certified that the company continues to meet the Hong Kong Main Board’s minimum public float threshold of 25% of issued shares.

No share options, warrants, convertible securities, or other equity-linked instruments were issued, exercised, or outstanding during the month, and there were no share repurchases, cancellations, or transfers.

The filing was authorised and submitted by Company Secretary Rosenna Ho on 3 August 2026, confirming full compliance with all applicable listing rules and regulatory requirements.